Global Immunology market was valued at $79.2 billion in 2019 with a CAGR of 8.2% from 2020 to 2026

Global Immunology Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)

Immunology is a study of immune system that protects the body from infection through various lines of defence. The dysfunction in the immune system can cause immunological disorders including allergy, autoimmune diseases, asthma, autoinflammatory syndromes and cancer. The immunological disorders can be treated form monoclonal antibody (mAb), immunosuppressants, polyclonal antibody (pAb), fusion proteins, and others.

The rising prevalence and incidence of chronic kidney diseases is a key driving factor of the market. According to the Centers for Disease Control and Prevention, the global prevalence of chronic kidney diseases is 13.4%. According to the Centers for Disease Control and Prevention, around 15% of US adults, which is 37 million people had chronic kidney diseases in 2020. In Canada, around 4 million people have chronic kidney diseases. According to the NHS England, more than 1.8 million people in England were diagnosed with chronic kidney disease (CKD) in 2019. Around 19•5 million have been diagnosed with chronic kidney disease in China. The prevalence of chronic kidney disease was 10.8% in 2019. According to the Australian Institute of Health and Welfare, around 1.7 million (10%) Australian adults with age 18 years and over had biomedical signs of chronic kidney disease (CKD).

Top key players @ Novartis AG, Amgen Inc., Astellas, ALLERGAN, Bristol-Myers Squibb Company, Pfizer Inc., Merck Sharp & Dohme Corp., Janssen Global Services, LLC (Johnson & Johnson), UCB SA, F. Hoffmann-La Roche Ltd, and AbbVie Inc.

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Get sample copy of this report @
https://www.infinitybusinessinsights.com/request_sample.php?id=512662

Calcium-based Phosphate Binders, Magnesium-based Phosphate Binders, Aluminum-based Phosphate Binders, Iron-based Phosphate Binders, and Other Phosphate Binders is the type segment of the market scope. By dosage form, the market is divided into Capsules, Tablets, and Syrups. The report covers the value of the global market by type and dosage form.

Based on dosage form, Tablets has shown significant growth in 2020, owing to the increasing regulatory approval of hyperphosphatemia tablets, the partnership between companies to expand its product portfolio and presence in the global market, and commercialization of new hyperphosphatemia tablets.

North America, Europe, Asia Pacific, South America, and Middle East & Africa are taken into consideration at the global hyperphosphatemia drugs value figures. While North America is further categorized into enhancing the United States, Canada, and Mexico, Europe is split into the United Kingdom, Germany, France, Italy, and Rest of Europe. Asia-Pacific covers India, China, Japan, South Korea, and Rest of Asia Pacific in its scope. South America is bifurcated into Brazil, Argentina, and Rest of South America, with Middle East & Africa involving GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the global hyperphosphatemia drugs market in 2020 due to the prevalence and incidence of chronic kidney diseases and the increasing prevalence of diabetes & osteoporosis across the region. In North America, the prevalence of chronic kidney diseases is very high in the elderly population, with more than 35% of patients over age 70 years suffering from stage 3 chronic kidney disease. Moreover, increasing regulatory approval for New Drug Application (NDA) for hyperphosphatemia drugs in the United States is boosting the market growth.

TABLE OF CONTENT:
1 Report Overview
2 Global Growth Trends
3 Market Share by Key Players
4 Breakdown Data by Type and Application
5 United States
6 Europe
7 China
8 Japan
9 Southeast Asia
10 India
11 Central & South America
12 International Players Profiles
13 Market Forecast 2019-2025
14 Analyst’s Viewpoints/Conclusions
15 Appendix

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:
Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering the services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.
We attain particular and niche demand of the industry while stabilize the quantum of standard with specified time and trace crucial movement at both the domestic and universal levels. The particular products and services provided by Infinity Business Insights cover vital technological, scientific and economic developments in industrial, pharmaceutical and high technology companies.

Contact Us:
Amit J
Sales Coordinator
+1-518-300-3575
amit@infinitybusinessinsights.com
https://mobile.twitter.com/IBInsightsLLP
https://facebook.com/Infinity-Business-Insights-352172809160429
https://www.linkedin.com/company/infinity-business-insights/

This release was published on openPR.